Targeting the neurovascular unit: development of a new model and consideration for novel strategy for Alzheimer's disease
- PMID: 21700401
- DOI: 10.1016/j.brainresbull.2011.05.015
Targeting the neurovascular unit: development of a new model and consideration for novel strategy for Alzheimer's disease
Abstract
Alzheimer's disease involves the complex and interconnected cascade of cellular and molecular events. Only a few treatments are available to slow the course of the disease at present. Recent studies suggest that neurovascular unit serves to maintain cerebral homeostasis, and pathological interactions between components of neurovascular unit lead to cerebral dysfunction. In present study, we established a functional unit trying to target major components of the neurovascular unit by the co-culture of rat cortical parenchymal culture and cerebral microvascular endothelial cells. This entity allowed the application of techniques such as immunofluorescent imaging and biological assays under defined conditions. The morphology of cell types, blood-brain barrier function and neuronal activation were investigated. The insight revealed that targeting components of the neurovascular unit, rather than just the neuron, might be a priority in Alzheimer's disease and more likely to provide cerebroprotection.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Ultrastructural features of the neurovascular unit in Alzheimer's neurodegeneration.J Physiol Pharmacol. 2006 Sep;57 Suppl 4:91-6. J Physiol Pharmacol. 2006. PMID: 17072034
-
Studying the neurovascular unit: an improved blood-brain barrier model.J Cereb Blood Flow Metab. 2009 Dec;29(12):1879-84. doi: 10.1038/jcbfm.2009.103. Epub 2009 Jul 29. J Cereb Blood Flow Metab. 2009. PMID: 19638997
-
A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.Neurochem Int. 2009 Mar-Apr;54(3-4):253-63. doi: 10.1016/j.neuint.2008.12.002. Epub 2008 Dec 7. Neurochem Int. 2009. PMID: 19111869
-
Neurovascular mechanisms of Alzheimer's neurodegeneration.Trends Neurosci. 2005 Apr;28(4):202-8. doi: 10.1016/j.tins.2005.02.001. Trends Neurosci. 2005. PMID: 15808355 Review.
-
Neurovascular unit dysfunction: a vascular component of Alzheimer disease?Neurology. 2007 May 15;68(20):1730-2. doi: 10.1212/01.wnl.0000264502.92649.ab. Neurology. 2007. PMID: 17502556 Review. No abstract available.
Cited by
-
Abnormal Glu/mGluR2/3/PI3K pathway in the hippocampal neurovascular unit leads to diabetes-related depression.Neural Regen Res. 2021 Apr;16(4):727-733. doi: 10.4103/1673-5374.296418. Neural Regen Res. 2021. PMID: 33063735 Free PMC article.
-
Effects of Amyloid Beta Peptide on Neurovascular Cells.Cent Asian J Glob Health. 2013 Feb 21;1(1):4. doi: 10.5195/cajgh.2012.4. eCollection 2012. Cent Asian J Glob Health. 2013. PMID: 29755858 Free PMC article. Review.
-
Drugs Modulating CD4+ T Cells Blood-Brain Barrier Interaction in Alzheimer's Disease.Pharmaceutics. 2020 Sep 16;12(9):880. doi: 10.3390/pharmaceutics12090880. Pharmaceutics. 2020. PMID: 32948022 Free PMC article. Review.
-
Cholic Acid Protects In Vitro Neurovascular Units against Oxygen and Glucose Deprivation-Induced Injury through the BDNF-TrkB Signaling Pathway.Oxid Med Cell Longev. 2020 Oct 10;2020:1201624. doi: 10.1155/2020/1201624. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33101581 Free PMC article.
-
Luteolin Inhibits Fibrillary β-Amyloid1-40-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-κB Signaling Pathways.Molecules. 2017 Feb 24;22(3):334. doi: 10.3390/molecules22030334. Molecules. 2017. PMID: 28245546 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical